These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27208794)

  • 1. Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.
    Mukherjee N; Dasgupta H; Bhattacharya R; Pal D; Roy R; Islam S; Alam N; Biswas J; Roy A; Roychoudhury S; Panda CK
    Biochim Biophys Acta; 2016 Sep; 1862(9):1472-84. PubMed ID: 27208794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of nuclear Y654-p-β-catenin expression through SH3GL2-meditated downregulation of EGFR in chemotolerance TNBC: Clinical and prognostic importance.
    Islam MS; Dasgupta H; Basu M; Roy A; Alam N; Roychoudhury S; Kumar Panda C
    J Cell Physiol; 2020 Nov; 235(11):8114-8128. PubMed ID: 31960967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance.
    Mukherjee N; Bhattacharya N; Alam N; Roy A; Roychoudhury S; Panda CK
    Cancer Sci; 2012 Feb; 103(2):210-20. PubMed ID: 22026417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
    Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
    Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
    He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
    Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications.
    Islam S; Dasgupta H; Basu M; Roy A; Alam N; Roychoudhury S; Panda CK
    Cell Oncol (Dordr); 2020 Aug; 43(4):725-741. PubMed ID: 32430683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alteration of CTNNBIP1 in Lung Cancer.
    Chang JM; Tsai AC; Huang WR; Tseng RC
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.
    Dey N; Young B; Abramovitz M; Bouzyk M; Barwick B; De P; Leyland-Jones B
    PLoS One; 2013; 8(10):e77425. PubMed ID: 24143235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner.
    Fu X; Zhu X; Qin F; Zhang Y; Lin J; Ding Y; Yang Z; Shang Y; Wang L; Zhang Q; Gao Q
    Mol Cancer; 2018 Mar; 17(1):73. PubMed ID: 29540185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.
    Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y
    Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer.
    Ozaki S; Ikeda S; Ishizaki Y; Kurihara T; Tokumoto N; Iseki M; Arihiro K; Kataoka T; Okajima M; Asahara T
    Oncol Rep; 2005 Dec; 14(6):1437-43. PubMed ID: 16273236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Wnt-β-catenin pathway in basal-parabasal layers of normal cervical epithelium comparable during development of uterine cervical carcinoma.
    Chakraborty C; Samadder S; Roychowdhury A; Roy A; Das P; Mandal RK; Roychoudhury S; Panda CK
    Mol Cell Biochem; 2018 Jun; 443(1-2):121-130. PubMed ID: 29079964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling.
    Liu L; Yu D; Shi H; Li J; Meng L
    Pharmazie; 2017 Oct; 72(10):599-603. PubMed ID: 29441885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
    Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC
    BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
    Shen H; Yan W; Yuan J; Wang Z; Wang C
    J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.
    Xu J; Chen Y; Huo D; Khramtsov A; Khramtsova G; Zhang C; Goss KH; Olopade OI
    Mol Carcinog; 2016 May; 55(5):431-9. PubMed ID: 25663530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.